Volitionrx (VNRX) Capital Expenditures (2011 - 2025)
Volitionrx's (VNRX) quarterly Capital Expenditures came in at $10967.0 in Q4 2025, down 84.89% YoY from $72601.0 in Q4 2024, and down 85.72% on a QoQ basis from $76783.0 in Q2 2025.
Volitionrx (VNRX) Capital Expenditures (2011 - 2025) Analysis & Trends
Volitionrx (VNRX) has 15 years of Capital Expenditures data on file, last reported at $10967.0 in Q4 2025.
- Quarterly Capital Expenditures fell 84.89% year-over-year to $10967.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $89558.0 (down 67.73% YoY) and the FY2025 annual result came in at $89558.0, down 67.73% from the prior year.
- Capital Expenditures fell to $10967.0 in Q4 2025, from $76783.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $578752.0 in Q4 2022 to a low of -$501986.0 in Q3 2023.
- A 5-year average of $171223.4 and a median of $128572.0 in 2021 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2022 — Capital Expenditures jumped 350.14% — and 2023, when it sank 254.23%.
- Tracing VNRX's Capital Expenditures over 5 years: stood at $128572.0 in 2021, then jumped by 350.14% to $578752.0 in 2022, then slumped by 186.74% to -$501986.0 in 2023, then surged by 114.46% to $72601.0 in 2024, then tumbled by 84.89% to $10967.0 in 2025.
- The last three Capital Expenditures figures came in at $10967.0 (Q4 2025), $76783.0 (Q2 2025), and $1808.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 497.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 202.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 195.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 66.90 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 84.70 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 100.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -74.39 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 87.50 Mn |
| 10 | Volitionrx | 1.19 Mn | -1.60 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10,967.00 |
| Dec 31, 2025 | 10,967.00 |
| Jun 30, 2025 | 76,783.00 |
| Jun 30, 2025 | 76,783.00 |
| Mar 31, 2025 | 1,808.00 |
| Mar 31, 2025 | 1,808.00 |
| Dec 31, 2024 | 72,601.00 |
| Dec 31, 2024 | 72,601.00 |
| Sep 30, 2024 | 136,737.00 |
| Sep 30, 2024 | 136,737.00 |
| Jun 30, 2024 | 18,161.00 |
| Jun 30, 2024 | 18,161.00 |
| Mar 31, 2024 | 50,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Sep 30, 2023 | -501,986.00 |
| Sep 30, 2023 | -501,986.00 |
| Jun 30, 2023 | 501,986.00 |
| Jun 30, 2023 | 501,986.00 |
| Dec 31, 2022 | 578,752.00 |
| Dec 31, 2022 | 578,752.00 |